The Economic Impact of Switching to Trastuzumab Biosimilar for the Treatment of Metastatic Breast Cancer from a Chinese Payer Perspective

Sep 1, 2018, 00:00
10.1016/j.jval.2018.07.018
https://www.valueinhealthjournal.com/article/S1098-3015(18)32374-X/fulltext
Title : The Economic Impact of Switching to Trastuzumab Biosimilar for the Treatment of Metastatic Breast Cancer from a Chinese Payer Perspective
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)32374-X&doi=10.1016/j.jval.2018.07.018
First page :
Section Title :
Open access? : No
Section Order : 150
Categories :
Tags :
Regions :
ViH Article Tags :